These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3012779)

  • 41. Persistence of a repressed Epstein-Barr virus genome in Burkitt lymphoma cells made resistant to 5-bromodeoxyuridine.
    Hampar B; Derge JG; Martos LM; Walker JL
    Proc Natl Acad Sci U S A; 1971 Dec; 68(12):3185-9. PubMed ID: 4332012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes.
    Woisetschlaeger M; Yandava CN; Furmanski LA; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1725-9. PubMed ID: 2155423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of Epstein-Barr virus infection and gene expression in human tumors by microarray analysis.
    Li C; Chen RS; Hung SK; Lee YT; Yen CY; Lai YW; Teng RH; Huang JY; Tang YC; Tung CP; Wei TT; Shieh B; Liu ST
    J Virol Methods; 2006 May; 133(2):158-66. PubMed ID: 16384612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of indomethacin on Epstein-Barr virus early antigen induction.
    Daniel LW; Bauer G; zur Hausen H
    Cancer Res; 1984 Mar; 44(3):981-3. PubMed ID: 6318991
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
    Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
    J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential expression of Epstein-Barr virus (EBV) genes BBRF3, BILF1, and BMRF2 in EBV-transformed lymphoblastoid lines from ataxia-telangiectasia patients.
    Becker Y; Tabor E; Asher Y
    Leukemia; 1988 Dec; 2(12 Suppl):178S-191S. PubMed ID: 2848995
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of n-butyrate on transformation of human lymphocytes by Epstein-Barr virus.
    Roubalová K; Roubal J
    Intervirology; 1985; 23(1):51-4. PubMed ID: 2982760
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Eradication of latent Epstein-Barr virus by hydroxyurea alters the growth-transformed cell phenotype.
    Chodosh J; Holder VP; Gan YJ; Belgaumi A; Sample J; Sixbey JW
    J Infect Dis; 1998 May; 177(5):1194-201. PubMed ID: 9593003
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early signals for keratinocyte differentiation: role of Ca2+-mediated inositol lipid metabolism in normal and neoplastic epidermal cells.
    Jaken S; Yuspa SH
    Carcinogenesis; 1988 Jun; 9(6):1033-8. PubMed ID: 2453303
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death.
    Inman GJ; Binné UK; Parker GA; Farrell PJ; Allday MJ
    J Virol; 2001 Mar; 75(5):2400-10. PubMed ID: 11160743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Baboon Endogenous C type Virus induces syncytium formation in Epstein barr virus (EBV) carrying lymphoblastoid human cell lines.
    Saal F; Cavalieri F; Sitbon M; Périés J
    Arch Virol; 1983; 75(1-2):151-5. PubMed ID: 6299243
    [No Abstract]   [Full Text] [Related]  

  • 53. Enhancement of Epstein-Barr virus-induced transformation of human lymphocytes by teleocidin.
    Hoshino HO; Miwa M; Fujiki H; Sugimura T; Yamamoto H; Katsuki T; Hinuma Y
    Cancer Lett; 1981 Sep; 13(4):275-80. PubMed ID: 6272962
    [No Abstract]   [Full Text] [Related]  

  • 54. Changes in the expression of Fc receptor produced by induction of Epstein-Barr virus in lymphoma cell lines.
    Yee C; Costa J; Hamilton V; Klein G; Rabson AS
    Virology; 1982 Jul; 120(2):376-82. PubMed ID: 6285610
    [No Abstract]   [Full Text] [Related]  

  • 55. Structural organization and expression of the Epstein-Barr virus genome.
    Bornkamm GW; Freese UK; Laux G; Hudewentz J; Delius H
    Haematol Blood Transfus; 1983; 28():295-6. PubMed ID: 6305801
    [No Abstract]   [Full Text] [Related]  

  • 56. Enhanced activation of the repressed Epstein-Barr viral genome by inhibitors of DNA synthesis.
    Hampar B; Derge JG; Showalter SD
    Virology; 1974 Mar; 58(1):298-301. PubMed ID: 4362552
    [No Abstract]   [Full Text] [Related]  

  • 57. Interferon production by a human lymphoblastoid cell line (DG-75) free of the Epstein-Barr genome.
    Lazar A; Reuveny S; Minai M; Traub A; Mizrahi A
    Antimicrob Agents Chemother; 1981 Aug; 20(2):151-4. PubMed ID: 6169305
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A new biflavonoid from Calophyllum panciflorum with antitumor-promoting activity.
    Ito C; Itoigawa M; Miyamoto Y; Rao KS; Takayasu J; Okuda Y; Mukainaka T; Tokuda H; Nishino H; Furukawa H
    J Nat Prod; 1999 Dec; 62(12):1668-71. PubMed ID: 10654415
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-frequency transfection of cultured human epidermal basal cells that differentiate to form a multilayered tissue.
    Jensen TG; Jensen PK; Nørgård JO; Bolund L
    Exp Cell Res; 1990 Aug; 189(2):163-8. PubMed ID: 2164480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. EBV-associated diseases: Current therapeutics and emerging technologies.
    Chakravorty S; Afzali B; Kazemian M
    Front Immunol; 2022; 13():1059133. PubMed ID: 36389670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.